The Impact of Health Care Reform on Addiction and HIV Services
医疗保健改革对成瘾和艾滋病毒服务的影响
基本信息
- 批准号:8836997
- 负责人:
- 金额:$ 44.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectBenchmarkingCD4 Lymphocyte CountCaliforniaCaringCharacteristicsClinicClinicalComorbidityComputerized Medical RecordCost SharingDataDeductiblesDemographic AccountingDiagnosisDiagnostic ServicesElementsEnrollmentFutureHIVHIV SeropositivityHealthHealth Care CostsHealth Care ReformHealth InsuranceHealth PlanningHealth PolicyHealth ServicesHealth Services AccessibilityHealthcareHealthcare SystemsIndividualInpatientsInterviewMeasuresMediatingMedicaidMedicalMethodsOrganizational ChangeOrganizational ModelsOutcomePatientsPatternPhaseRegistriesRouteSamplingServicesSilverSocioeconomic StatusStatutes and LawsSubstance Use DisorderSystemTimeTreatment CostViralVulnerable PopulationsWorkaddictionbasecohortcostdemographicsdesignhealth care deliveryhealth care service utilizationimplementation researchimprovedinnovationmemberpatient populationresponsescreeningservice utilizationtheories
项目摘要
Health care reform legislation has significant implications for access to services and expansion of
benefits for those with substance use disorders (SUD), particularly those with HIV. These conditions are
associated with multiple medical and psychiatric comorbidities as well as high health care costs. Responding to
RFA-DA-13-001, the proposed study focuses on key elements of the Affordable Care Act (ACA) that will be
implemented in 2014 and will likely increase demand for SUD and HIV treatment services. The study evaluates
the impact of the ACA on individuals with SUDs in a care setting well-suited to ACA implementation research.
Kaiser Permanente Northern California (KPNC) is a large health care system providing integrated SUD and
medical treatment and has been designated as the statewide benchmark for small group plans in the California
health insurance exchange. Our innovative approach is informed by an integrated conceptual model of
organizational theory and health service utilization. In this phased study, the Aims of the R21 phase lay the
groundwork for analyzing changes in membership demographics and clinical complexity, services use and
costs, using a cohort (n=3641) of newly enrolled pre-ACA health plan members with SUDs, including members
with both SUDs and HIV. In the R33 phase, we use a pre-post design to compare the R21 cohort to a second,
post-ACA cohort of newly enrolled KPNC members with SUDs, using advanced difference-in-difference
methods to analyze ACA-related changes that begin in 2014. Key outcomes include membership changes,
health services utilization and costs, SUD treatment initiation and retention, and HIV management. The post-
ACA cohort will also be followed longitudinally over two years. With an innovative mixed-methods approach,
we use data from the health plans extensive electronic medical record, supplemented by qualitative interviews
with organizational and clinical leaders regarding ACA-related changes to benefit plans, service delivery,
workforce, and barriers or facilitators that impact ACA implementation. Findings will be highly informative in
understanding how health plans implement the ACA and serve newly insured SUD and HIV patient
populations, and will contribute to future health policy.
卫生保健改革立法对获得服务和扩大保健服务具有重大影响。
对物质使用障碍(SUD)患者,特别是艾滋病毒感染者的益处。这些条件
与多种医学和精神病合并症以及高医疗保健费用相关。应对
RFA-DA-13-001,拟议的研究重点是平价医疗法案(ACA)的关键要素,
该计划将于2014年实施,并可能增加对SUD和艾滋病毒治疗服务的需求。该研究评估了
ACA对SUD患者在护理环境中的影响非常适合ACA实施研究。
Kaiser Permanente北方加州(KPNC)是一个大型医疗保健系统,提供综合SUD和
医疗,并已被指定为全州的基准,为小团体计划在加州
健康保险交易所我们的创新方法是由一个综合的概念模型,
组织理论与卫生服务利用。在这项分阶段研究中,R21阶段的目标是
分析会员人口统计学和临床复杂性、服务使用和
费用,使用新入组的患有SUD的ACA前健康计划成员队列(n=3641),包括成员
感染了SUD和HIV在R33阶段,我们使用前后设计将R21队列与第二个队列进行比较,
新入组的SUD KPNC成员的ACA后队列,使用高级差异中差异
分析ACA相关变化的方法,这些变化开始于2014年。主要成果包括成员变化,
卫生服务的利用和成本,SUD治疗的启动和保留,以及艾滋病毒管理。邮报-
ACA队列也将在两年内进行纵向随访。通过创新的混合方法,
我们使用健康计划的数据广泛的电子病历,辅以定性访谈
与组织和临床负责人就ACA相关的福利计划、服务交付的变更进行沟通,
劳动力,以及影响ACA实施的障碍或促进因素。调查结果将提供大量信息,
了解健康计划如何实施ACA并为新投保的SUD和HIV患者提供服务
这将有助于未来的卫生政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CYNTHIA I CAMPBELL其他文献
CYNTHIA I CAMPBELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CYNTHIA I CAMPBELL', 18)}}的其他基金
Role of Health Care in Addressing Unhealthy Alcohol Use and Disparities among Aging Women
医疗保健在解决老年妇女不健康饮酒和差异方面的作用
- 批准号:
10505016 - 财政年份:2022
- 资助金额:
$ 44.03万 - 项目类别:
Role of Health Care in Addressing Unhealthy Alcohol Use and Disparities among Aging Women
医疗保健在解决老年妇女不健康饮酒和差异方面的作用
- 批准号:
10705652 - 财政年份:2022
- 资助金额:
$ 44.03万 - 项目类别:
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
丁丙诺啡和针对处方阿片类药物依赖的药物滥用服务
- 批准号:
8927597 - 财政年份:2014
- 资助金额:
$ 44.03万 - 项目类别:
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
丁丙诺啡和针对处方阿片类药物依赖的药物滥用服务
- 批准号:
9114551 - 财政年份:2014
- 资助金额:
$ 44.03万 - 项目类别:
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
丁丙诺啡和针对处方阿片类药物依赖的药物滥用服务
- 批准号:
8614727 - 财政年份:2014
- 资助金额:
$ 44.03万 - 项目类别:
The Impact of Health Care Reform on Addiction and HIV Services
医疗保健改革对成瘾和艾滋病毒服务的影响
- 批准号:
8535420 - 财政年份:2013
- 资助金额:
$ 44.03万 - 项目类别:
The Impact of Health Care Reform on Addiction and HIV Services
医疗保健改革对成瘾和艾滋病毒服务的影响
- 批准号:
8823048 - 财政年份:2013
- 资助金额:
$ 44.03万 - 项目类别:
High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories
高免赔额健康计划:药物滥用服务的使用和成本轨迹
- 批准号:
8023874 - 财政年份:2011
- 资助金额:
$ 44.03万 - 项目类别:
High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories
高免赔额健康计划:药物滥用服务的使用和成本轨迹
- 批准号:
8330816 - 财政年份:2011
- 资助金额:
$ 44.03万 - 项目类别:
Alcohol Trajectories and Service Use in Young Adults: Nine Years Post Treatment
年轻人的酒精轨迹和服务使用:治疗后九年
- 批准号:
7890142 - 财政年份:2010
- 资助金额:
$ 44.03万 - 项目类别:
相似国自然基金
企业绩效评价的DEA-Benchmarking方法及动态博弈研究
- 批准号:70571028
- 批准年份:2005
- 资助金额:16.5 万元
- 项目类别:面上项目
相似海外基金
An innovative EDI data, insights & peer benchmarking platform enabling global business leaders to build data-led EDI strategies, plans and budgets.
创新的 EDI 数据、见解
- 批准号:
10100319 - 财政年份:2024
- 资助金额:
$ 44.03万 - 项目类别:
Collaborative R&D
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
- 批准号:
2796588 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Elements: CausalBench: A Cyberinfrastructure for Causal-Learning Benchmarking for Efficacy, Reproducibility, and Scientific Collaboration
要素:CausalBench:用于因果学习基准测试的网络基础设施,以实现有效性、可重复性和科学协作
- 批准号:
2311716 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Standard Grant
Benchmarking collisional rates and hot electron transport in high-intensity laser-matter interaction
高强度激光-物质相互作用中碰撞率和热电子传输的基准测试
- 批准号:
2892813 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Collaborative Research: SHF: Medium: A Comprehensive Modeling Framework for Cross-Layer Benchmarking of In-Memory Computing Fabrics: From Devices to Applications
协作研究:SHF:Medium:内存计算结构跨层基准测试的综合建模框架:从设备到应用程序
- 批准号:
2347024 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Standard Grant
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
- 批准号:
2233969 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Continuing Grant
FET: Medium: Quantum Algorithms, Complexity, Testing and Benchmarking
FET:中:量子算法、复杂性、测试和基准测试
- 批准号:
2311733 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Continuing Grant
Establishing and benchmarking advanced methods to comprehensively characterize somatic genome variation in single human cells
建立先进方法并对其进行基准测试,以全面表征单个人类细胞的体细胞基因组变异
- 批准号:
10662975 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
- 批准号:
2233968 - 财政年份:2023
- 资助金额:
$ 44.03万 - 项目类别:
Continuing Grant














{{item.name}}会员




